- ►prsjournal.com AL Takeda, J Colquitt, AJ Clegg, J Jones - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: Three RCTs of ranibizumab (MARINA, ANCHOR, FOCUS) and two of pegaptanib
(VISION study) met the inclusion criteria. The RCTs included patients with
different lesion types. The studies showed statistically significant ... Cited by 36 - Related articles - BL Direct - All 6 versions
J Bradley, M Ju, GS Robinson - Angiogenesis, 2007 - Springer Abstract The growth of inappropriately regulated, leaky blood vessels is a
prominent component of sev- eral debilitating eye diseases, such as age-related
macular degeneration (AMD), proliferative diabetic retinopathy (PDR), and ... Cited by 36 - Related articles - BL Direct - All 3 versions
- ►iovs.org BR Mwaikambo, F Sennlaub, H Ong, S … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. In a murine model of inflammatory CNV, CD36 expression was evaluated by
RT-PCR and immunofluorescence. Mice subjected to CNV were treated topically
(thrice daily) with CD36 functionally neutralizing antibodies against the ... Cited by 17 - Related articles - BL Direct - All 3 versions
B Desvergne - Nature medicine, 2007 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications
AZ index; Browse by subject. My account; Submit manuscript; ... Cited by 5 - Related articles - BL Direct - All 5 versions
J Adamkiewicz, K Kaddatz, M Rieck, B Wilke, S … - Proteomics, 2007 - imt.uni-marburg.de The peroxisome proliferator activated receptor-b (PPARb) plays an essential role
in lipid metab- olism, immune modulation, differentiation and cell
proliferation. There is also strong evidence for a function in oncogenesis ... Cited by 9 - Related articles - View as HTML - BL Direct - All 6 versions
AAOFO AAO - clienti.tio.ch Jeffrey Heier (Department of Ophthalmology, Harvard Medical School, Boston, MA,
USA) presented updated findings from the ANCHOR (Anti-VEGF Antibody for the
Treatment of Predominantly Classic Choroidal Neo- vascularisation in ... Related articles - View as HTML
- ►prsjournal.com UM Schmidt-Erfurth, G Richard, A Augustin, … - Acta Ophthalmologica Scandinavica, 2007 - pt.wkhealth.com Neovascular age-related macular degeneration is becoming an increasing
socio-medical problem as the proportion of the aged population is continuously
increasing. However, new insights in the pathogenesis of the disease offer ... Cited by 28 - Related articles - BL Direct - All 8 versions
RP Singh - members.medscape.com Jason Slakter [1] presented 1-year optical coherence tomographic (OCT) and
fluorescein angiographic results from the CLEAR-IT 2 trial -- a double-masked,
multicenter, phase 2 trial that is examining the use of intravitreal VEGF ... Cited by 1 - Related articles - All 2 versions
JI Lim - jhasio.com Over the past decade, treatment of neovascular age-related macular degeneration
has evolved from overall retinal ablation to more targeted and retinal-sparing
therapy, beginning with the advent of photodynamic therapy and continuing ... Related articles
- ►medscape.com CME Tracker - medscape.com Ever since the initial results showing visual acuity gains with the use of the
anti-vascular endothelial growth factor (VEGF) agent ranibizumab for age-related
macular degeneration were presented, the retinal community has been abuzz ... Related articles - All 5 versions
